Holen Sie sich die Stockscreener-App
2.96
5.71%
0.16
Vorhandelsmarkt:
2.96
Finanzdaten der Abvc Biopharma Inc-Aktie (ABVC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
0.00197 | 0.3893 | 0.1171 | 0.00121 |
Operating Expenses
|
106.18%
0.693
|
0.3361 | 0.339 | 1.0936 | 3.4453 |
| Operating Income/Loss |
107.39%
-0.693
|
-0.3342 | 0.0499 | -0.9766 | -3.4444 |
| Nonoperating Income/Loss |
154.24%
-0.2512
|
0.4631 | -0.1839 | -0.4069 | -0.5366 |
| Income/Loss Before Equity Method Investments |
-0.8933
|
- | -0.066 | - | - |
| Income/Loss From Equity Method Investments |
-0.0509
|
- | -0.0679 | - | - |
| Income/Loss From Continuing Operations Before Tax |
832.25%
-0.9442
|
0.1289 | -0.1339 | -1.3836 | -3.981 |
| Income/Loss From Continuing Operations After Tax |
832.25%
-0.9442
|
0.1289 | -0.1343 | -1.2727 | -3.981 |
|
Net Income/Loss
|
832.25%
-0.9442
|
0.1289 | -0.1343 | -1.2727 | -3.981 |
| Preferred Stock Dividends And Other Adjustments |
82.42%
-1.7863
|
-10.16 | - | - | - |
| Attributable To Noncontrolling Interest |
1.75%
-0.1021
|
-0.1004 | 0.0523 | -0.26 | -0.048 |
| Basic Average Shares |
2,836%
14.97
|
0.5099 | 12.41 | 11.32 | 9.7362 |
| Diluted Average Shares |
2,836%
14.97
|
0.5099 | 12.41 | 11.32 | 9.7362 |
| Basic Earnings Per Share |
250.00%
-0.06
|
0.04 | -0.02 | -0.09 | -0.40 |
| Diluted Earnings Per Share |
250.00%
-0.06
|
0.04 | -0.02 | -0.09 | -0.40 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
82.42%
-1.7863
|
-10.16 | - | - | - |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):